COVID-19 and Hypertension: A Mini-Review of Their Mutual Effect

References (36)

1. 1 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study [DOI]
2. 2 Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China [DOI]
3. 3 La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
4. 4 Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area [DOI]
5. 5 Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China [DOI]
6. 6 Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis [DOI]
7. 7 Incidence of thrombotic complications in critically ill ICU patients with COVID-19 [DOI]
8. 8 Estimates of the severity of coronavirus disease 2019: a model-based analysis [DOI]
9. 9 A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injury [DOI]
10. 10 A Novel Angiotensin-Converting Enzyme–Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1-9 [DOI]
11. 11 COVID-19 pathophysiology: A review [DOI]
12. 12 Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 [DOI]
13. 13 2020 International Society of Hypertension global hypertension practice guidelines [DOI]
14. 14 ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia [DOI]
15. 15 Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence [DOI]
16. 16 Counter-regulatory renin–angiotensin system in cardiovascular disease [DOI]
17. 17 Coronavirus Disease 2019 (COVID‐19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 Infection [DOI]
18. 18 Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study [DOI]
19. 19 Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study [DOI]
20. 20 Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression [DOI]
21. 21 Pulmonary Angiotensin-Converting Enzyme 2 (ACE2) and Inflammatory Lung Disease [DOI]
22. 22 Hypertension: pathophysiology and treatment [DOI]
23. 23 ACE2–angiotensin-(1–7)–Mas axis and oxidative stress in cardiovascular disease [DOI]
24. 24 The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19 [DOI]
25. 25 O Efeito da Doença de Coronavírus 2019 nas Doenças Cardiovasculares [DOI]
26. 26 COVID‐19 and hypertension—evidence and practical management: Guidance from the HOPE Asia Network [DOI]
27. 27 Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension [DOI]
28. 28 Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysis [DOI]
29. 29 Renin-Angiotensin-Aldosterone System Inhibitors and Risks of Severe Acute Respiratory Syndrome Coronavirus 2 Infection [DOI]
30. 30 Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people [DOI]
31. 31 Expression of Renin-Angiotensin System Components in the Heart, Kidneys, and Lungs of Rats With Experimental Heart Failure [DOI]
32. 32 Managing hypertension during the COVID-19 pandemic [DOI]
33. 33 2020 International Society of Hypertension Global Hypertension Practice Guidelines [DOI]
34. 34 Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? [DOI]
35. 35 Hypertension and COVID-19 [DOI]
36. 36 Hypertension and the prothrombotic state [DOI]

Cited by 0

No indexed citations yet.

Related research

• Dietary Pattern and Prevalence of High Blood Pressure among Adult Traders in Port Harcourt, Nigeria — shares topic coverage
• Impact of the Diet Profile and Alcohol Consumption on Cardiometabolic Risks in Dschang Health District-Cameroon — shares topic coverage
• Gender Specific Predictive Performance and Optimal Threshold of Anthropometric Indices for the Prediction of Hypertension among a Ghanaian Population in Kumasi — shares topic coverage
• Metabolic Syndrome and Kidney Damage: Prevalence and Assessment of Risk among Apparently Healthy Resident of Ado Ekiti, South West Nigeria — shares topic coverage
• Analysis of Risk Factors among Diabetic Patients Visiting Diabetic Research Clinic at Nishtar Hospital Multan-Pakistan — shares topic coverage